RELAPSED/REFRACTORY

Clinical trials for RELAPSED/REFRACTORY explained in plain language.

Never miss a new study

Get alerted when new RELAPSED/REFRACTORY trials appear

Sign up with your email to follow new studies for RELAPSED/REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Phase i clinical study on the safety and tolerability of IASO206 injection in patients with Relapsed/Refractory autoimmune hemolytic anemia

Not yet recruiting

This study is an open-label, single-arm early exploratory clinical study, aiming to evaluate the safety, tolerability and preliminary efficacy of IASO206 Injection (In Vivo CAR-T) in Patients with Relapsed/Refractory Autoimmune Hemolytic Anemia

Matched conditions: RELAPSED/REFRACTORY

Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China

Last updated May 17, 2026 05:29 UTC

RELAPSED/REFRACTORY

Get alerted when new RELAPSED/REFRACTORY trials appear

Phase i clinical study on the safety and tolerability of IASO206 injection in patients with Relapsed/Refractory autoimmune hemolytic anemia